NEW YORK, June 16, 2021 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), a leader in the global digital therapeutics (DTx)
market, announced today the launch of the Upright GO S, a new
wearable sensor based on the company's pioneering biofeedback
technologies to make better back health accessible to more
people.
This new product from Upright, by Dario, is part of the
company's planned growth strategy for increasing platform
membership across both business partnerships and consumer channels.
Currently, Dario has more than 185,000 members across its
integrated suite of digital therapeutics for chronic and mental
health needs.
"One of the strengths of Upright's sensor-based solutions is the
successful track record of consumer adoption. The Upright GO S
continues that legacy by offering a more affordable option to make
digital health solutions accessible to a larger number of people in
support of our mission and membership growth strategy," said
Erez Raphael, CEO of
DarioHealth.
New research published in the journal Demography
documents the growing prevalence of chronic back and neck pain in
U.S. adults, with the greatest increase in pain affecting those in
lower socioeconomic classes.1 Employers are also paying
attention, as back pain becomes a significant problem for their
populations, especially for employees who spend significant amounts
of time sitting. In addition, a recent survey of Upright by Dario
users found that 78% agree that the increase in sedentary
activities during the day are negatively impacting their health,
further illustrating the need for preventative
approaches.
The Upright GO S represents an advancement in our sensor
technology and addresses the demand for more accessible
musculoskeletal care across our consumer base. In addition, the
Upright Go S presents an attractive option for cost-conscious
consumers which we anticipate will enhance the diversity of the
members on our platform. Increased diversity of our membership
allows our AI-powered personalization engine to provide more
tailored experiences to a broader set of users.
1 Anna Zajacova, Hanna
Grol-Prokopczyk, Zachary
Zimmer; Pain Trends Among American Adults, 2002–2018:
Patterns, Disparities, and Correlates. Demography 1 April 2021; 58 (2): 711–738. doi:
https://doi.org/10.1215/00703370-8977691
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital
therapeutics company revolutionizing how people with chronic
conditions manage their health. Dario's next-generation,
AI-powered, digital therapeutic solutions support more than just an
individual's disease. Dario provides adaptive, personalized
experiences that drive behavior change through evidence-based
interventions, intuitive, clinically proven digital tools,
high-quality software, and coaching to help individuals improve
health and sustain meaningful outcomes. Dario offers one of the
highest-rated diabetes and hypertension solutions on the market.
The company's cross-functional team operates at the intersection of
life sciences, behavioral science, and software technology and is
rapidly expanding into new chronic conditions and geographic
markets, using a performance-based approach to improve its users'
health. Dario makes the right thing to do the easy thing to do. To
learn more about DarioHealth and its digital health solutions, or
for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it discusses
that the more it diversifies members across demographics and
socio-economic factors, the better informed and less biased the
AI-powered personalization engine becomes and its belief that the
impact of the last year on people's health is driving incredible
demand for more accessible musculoskeletal care across its consumer
and client bases. Without limiting the generality of the foregoing,
words such as "plan," "project," "potential," "seek," "may,"
"will," "expect," "believe," "anticipate," "intend," "could,"
"estimate" or "continue" are intended to identify forward-looking
statements. Readers are cautioned that certain important factors
may affect the Company's actual results and could cause such
results to differ materially from any forward-looking statements
that may be made in this news release. Factors that may affect the
Company's results include, but are not limited to, regulatory
approvals, product demand, market acceptance, impact of competitive
products and prices, product development, commercialization or
technological difficulties, the success or failure of negotiations
and trade, legal, social and economic risks, and the risks
associated with the adequacy of existing cash resources. Additional
factors that could cause or contribute to differences between the
Company's actual results and forward-looking statements include,
but are not limited to, those risks discussed in the Company's
filings with the U.S. Securities and Exchange Commission. Readers
are cautioned that actual results (including, without limitation,
the timing for and results of the Company's commercial and
regulatory plans for Dario™ as described herein) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate Contact
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220
Media Contact:
Josephine
Galatioto
Josephine.Galatioto@russopartnersllc.com
+1-212-845-4262
View original
content:http://www.prnewswire.com/news-releases/dariohealth-expands-footprint-in-musculoskeletal-sensor-technologies-with-the-upright-go-s-301313663.html
SOURCE DarioHealth Corp.